Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-03-09FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-06FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Mylan Pharmaceuticals Inc., indicating approval of a supplemen…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) [Phase 2]
Phase 2 trial assessing preventive measures for childhood-onset obsessive-compulsive disorder and tic disorders within the PANDAS subgroup h…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections [Phase 4]
Phase 4 clinical trial investigates amoxicillin for pediatric autoimmune neuropsychiatric conditions associated with streptococcal infection…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Cortical Excitability in Obsessive-Compulsive and Related Disorders
Completed clinical trial examining cortical excitability in obsessive-compulsive disorder and healthy controls.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
This is a completed clinical trial update describing brain imaging studies of serotonin metabolism using an I-123 radiotracer in healthy vol…
-
FDA approval · 2008-02-14FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine from Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD) [Phase 3]
A Phase 3 clinical trial assessing behavior therapy for children and adolescents with obsessive-compulsive disorder has completed.
-
FDA approval · 2008-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic paroxetine hydrochloride product (PAROXETINE HYDROCHLORIDE).
-
CLINICAL_TRIALS withdrawal · 2008-01-31Clinical Trial Update: Treatment With Duloxetine for OCD Patients [NA]
A clinical trial evaluating duloxetine for Obsessive-Compulsive Disorder has been withdrawn.
-
FDA approval · 2008-01-31FDA Approved: FLUOXETINE — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved the original application for a generic fluoxetine hydrochloride product from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients [NA]
A completed clinical trial assessing the efficacy of naltrexone as augmentation to SSRI therapy in patients with obsessive-compulsive disord…
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Short Term Group Therapy for OCD [NA]
A completed clinical trial update evaluating short-term group therapy for obsessive-compulsive disorder.
-
CLINICAL_TRIALS withdrawal · 2008-01-29Clinical Trial Update: OCD Among Patients With Burns
The study titled 'Clinical Trial Update: OCD Among Patients With Burns' was withdrawn; it involved Obsessive-Compulsive Disorder in patients…
-
FDA approval · 2008-01-11FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a sertraline generic product from Heritage Pharmaceuticals (Avet), authorizing changes to the ap…
-
FDA approval · 2008-01-08FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s sertraline hydrochloride generic under an Original Application. The approval provides a generic…
-
CLINICAL_TRIALS research · 2007-12-27Clinical Trial Update: Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
A completed clinical trial investigated whether chronic schizophrenia with obsessive-compulsive symptoms is best characterized as comorbidit…
-
FDA approval · 2007-12-26FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (generic) from Aurobindo Pharma Limited, updating the regulatory status…
-
FDA approval · 2007-12-20FDA Approved: FLUVOXAMINE MALEATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved fluvoxamine maleate via ANI Pharmaceuticals' Original Application, marking the approval of this product. The decision makes…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Quetiapine Augmentation in Severe Obsessive Compulsive Disorder [Phase 3]
A Phase 3 trial evaluating quetiapine augmentation in adults with severe obsessive-compulsive disorder has completed.
-
FDA approval · 2007-10-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic sertraline product, under the ANDA.
-
FDA approval · 2007-10-16FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for fluvoxamine maleate filed by Chartwell RX, LLC.
-
FDA approval · 2007-10-10FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett Company's supplemental application for fluoxetine hydrochloride, a generic version of fluoxetine.
-
FDA approval · 2007-09-28FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., resulting in an approved label update for this g…
-
FDA approval · 2007-09-14FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for fluvoxamine maleate from Upsher-Smith Laboratories, confirming approval of the generic formu…